IL158285A0 - Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-base assay for determination of immune responses against oxidized low density lipoprotein - Google Patents
Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-base assay for determination of immune responses against oxidized low density lipoproteinInfo
- Publication number
- IL158285A0 IL158285A0 IL15828502A IL15828502A IL158285A0 IL 158285 A0 IL158285 A0 IL 158285A0 IL 15828502 A IL15828502 A IL 15828502A IL 15828502 A IL15828502 A IL 15828502A IL 158285 A0 IL158285 A0 IL 158285A0
- Authority
- IL
- Israel
- Prior art keywords
- peptide
- atherosclerosis
- determination
- development
- treatment
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 238000002649 immunization Methods 0.000 title abstract 2
- 230000003053 immunization Effects 0.000 title abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 title 1
- 238000003556 assay Methods 0.000 title 1
- 230000028993 immune response Effects 0.000 title 1
- 108010071584 oxidized low density lipoprotein Proteins 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 2
- 238000002965 ELISA Methods 0.000 abstract 2
- 230000000302 ischemic effect Effects 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 101710095342 Apolipoprotein B Proteins 0.000 abstract 1
- 102100040202 Apolipoprotein B-100 Human genes 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Marine Sciences & Fisheries (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0101232A SE0101232D0 (sv) | 2001-04-05 | 2001-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based elisa for determination of immune responses against oxidized low density liprotein |
| SE0103754A SE0103754L (sv) | 2001-04-05 | 2001-11-09 | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid |
| PCT/SE2002/000679 WO2002080954A1 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL158285A0 true IL158285A0 (en) | 2004-05-12 |
Family
ID=26655437
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15828502A IL158285A0 (en) | 2001-04-05 | 2002-04-05 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-base assay for determination of immune responses against oxidized low density lipoprotein |
| IL158285A IL158285A (en) | 2001-04-05 | 2003-10-07 | Peptides for preparing medicament for immuno- therapy of atherosclerosis and development of peptide-base assay for determination of immune responses against oxidized low density lipoprotein |
| IL188286A IL188286A0 (en) | 2001-04-05 | 2007-12-20 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| IL195356A IL195356A0 (en) | 2001-04-05 | 2008-11-18 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL158285A IL158285A (en) | 2001-04-05 | 2003-10-07 | Peptides for preparing medicament for immuno- therapy of atherosclerosis and development of peptide-base assay for determination of immune responses against oxidized low density lipoprotein |
| IL188286A IL188286A0 (en) | 2001-04-05 | 2007-12-20 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| IL195356A IL195356A0 (en) | 2001-04-05 | 2008-11-18 | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
Country Status (18)
| Country | Link |
|---|---|
| EP (42) | EP2289921A1 (sv) |
| JP (6) | JP2004529143A (sv) |
| CN (4) | CN103122031B (sv) |
| AT (2) | ATE415423T1 (sv) |
| AU (1) | AU2002246484B8 (sv) |
| BR (1) | BR0208685A (sv) |
| CA (3) | CA2443223C (sv) |
| CY (1) | CY1108817T1 (sv) |
| DE (1) | DE60230029D1 (sv) |
| DK (3) | DK1383526T3 (sv) |
| EE (2) | EE200300487A (sv) |
| ES (2) | ES2317999T3 (sv) |
| IL (4) | IL158285A0 (sv) |
| PL (4) | PL367301A1 (sv) |
| PT (1) | PT1383526E (sv) |
| RU (1) | RU2296582C2 (sv) |
| SE (1) | SE0103754L (sv) |
| WO (1) | WO2002080954A1 (sv) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030105003A1 (en) | 2001-04-05 | 2003-06-05 | Jan Nilsson | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| SE0103754L (sv) * | 2001-04-05 | 2002-10-06 | Forskarpatent I Syd Ab | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid |
| JP2005504085A (ja) | 2001-09-28 | 2005-02-10 | エスペリオン セラピューティクス，インコーポレイテッド | 薬剤の局所投与による再狭窄の予防および治療 |
| SE0302312D0 (sv) | 2002-10-04 | 2003-08-27 | Forskarpatent I Syd Ab | Peptide-based passive immunization therapy for treatment of atherosclerosis |
| AU2003267905B2 (en) * | 2002-10-04 | 2009-02-05 | Biolnvent International Ab | Peptide-based passive immunization therapy for treatment of atherosclerosis |
| SE0302422D0 (sv) * | 2003-09-11 | 2003-09-11 | Forskarpatent I Syd Ab | Peptide-based immunization therapy for treatment of atherosclerosis |
| SE0400683D0 (sv) | 2004-03-19 | 2004-03-19 | Forskarpatent I Syd Ab | Use of modified extracellular matrix proteins in diagnosis and treatment of a atherosclerosis |
| JP2007531537A (ja) | 2004-04-06 | 2007-11-08 | セダーズ−シナイ メディカル センター | アポリポタンパク質ａ−ｉおよびアポリポタンパク質ａ−ｉｍｉｌａｎｏをコードする組換えアデノ随伴ウイルスベクターによる血管疾患の予防および処置 |
| CA2776927C (en) * | 2004-04-15 | 2014-08-12 | Athera Biotechnologies Ab | Phosphorylcholine conjugates and corresponding antibodies |
| EP1676602A1 (en) | 2005-01-04 | 2006-07-05 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis |
| GB0517878D0 (en) | 2005-09-02 | 2005-10-12 | Bioinvent Int Ab | Immunotherapeutic treatment |
| CA2669863A1 (en) * | 2006-12-22 | 2008-07-03 | Abbott Laboratories | Cardiovascular autoimmune disease panel and methods of using same |
| WO2008104194A1 (en) * | 2007-02-28 | 2008-09-04 | Bioinvent International Ab | Oxidized ldl and antibodies thereto for the treatment of atheroscleroti c plaques |
| SG182205A1 (en) | 2007-03-15 | 2012-07-30 | Novartis Ag | Organic compounds and their uses |
| EP2538221A3 (en) * | 2007-11-05 | 2013-04-24 | Nordic Bioscience A/S | Biochemical markers for CVD risk assessment |
| US20100041663A1 (en) | 2008-07-18 | 2010-02-18 | Novartis Ag | Organic Compounds as Smo Inhibitors |
| EP2319924B1 (en) * | 2008-08-15 | 2016-03-09 | Fujikura Kasei Co., Ltd. | Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis |
| WO2011060329A1 (en) | 2009-11-14 | 2011-05-19 | Kuang-Yuh Chyu | Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis |
| US8506964B2 (en) | 2010-02-05 | 2013-08-13 | Cardiovax, Llc | Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis |
| US20130142760A1 (en) | 2010-08-18 | 2013-06-06 | Cedars-Sinai Medical Center | Atherosclerosis inhibition via modulation of monocyte-macrophage phenotype using apo a-i milano gene transfer |
| EP2637689A2 (en) | 2010-11-12 | 2013-09-18 | Cedars-Sinai Medical Center | Immunomodulatory methods and systems for treatment and/or prevention of hypertension |
| JP2013544243A (ja) * | 2010-11-12 | 2013-12-12 | シーダース シナイ メディカル センター | 動脈瘤の治療及び／又は予防のための免疫調節方法及びシステム |
| AU2011325948A1 (en) * | 2010-11-12 | 2013-05-30 | Cedars-Sinai Medical Center | Immunomodulatory compositions, methods and systems comprising immunogenic fragments of Apob100 |
| DK2742068T3 (da) | 2011-08-09 | 2019-06-11 | Athera Biotechnologies Ab | Nye antistoffer mod phosphorylcholin |
| CA2843960C (en) | 2011-08-09 | 2020-09-15 | Athera Biotechnologies Ab | Antibodies binding to phosphorylcholine (pc) and/or pc conjugates |
| RU2495048C1 (ru) * | 2012-04-18 | 2013-10-10 | Андрей Валентинович Исаев | Пептид, обладающий антиатеросклеротическим действием и композиция для профилактики и лечения атеросклероза сосудов |
| MX364626B (es) | 2012-11-06 | 2019-05-03 | Les Hopitaux Univ De Geneve | Péptidos miméticos. |
| CN103520713B (zh) * | 2013-10-16 | 2015-10-28 | 西北农林科技大学 | 一种ApoB100酵母重组疫苗及其制备方法和应用 |
| CN103860470A (zh) * | 2014-03-05 | 2014-06-18 | 贵州中泰生物科技有限公司 | 一种口服高密度脂蛋白脂质体的制备方法 |
| CN105315364B (zh) * | 2014-06-17 | 2018-09-18 | 广州文瑞生物科技有限公司 | 胶原蛋白vi疫苗预防动脉粥样硬化 |
| WO2016187250A1 (en) * | 2015-05-19 | 2016-11-24 | La Jolla Institute For Allergy And Immunology | Human apob100 epitopes, methods and uses for modulating inflammatory responses, and treating adverse cardiovascular events, disease and atherosclerosis |
| US10858422B2 (en) | 2016-05-31 | 2020-12-08 | Abcentra, Llc | Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody |
| CN108478817B (zh) * | 2018-03-16 | 2020-10-27 | 北京大学 | 一种动脉粥样硬化检测试剂及其制备方法 |
| WO2019232070A1 (en) | 2018-05-29 | 2019-12-05 | Abcentra, Llc | Compositions and methods for treatment of psoriasis |
| CA3129373A1 (en) | 2018-05-29 | 2019-12-05 | Abcentra, Llc | Compositions and methods for treatment of rheumatoid arthritis and accelerated atherosclerosis |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4970144A (en) | 1984-12-31 | 1990-11-13 | International Genetic Engineering | Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use |
| US5972890A (en) | 1988-05-02 | 1999-10-26 | New England Deaconess Hospital Corporation | Synthetic peptides for arterial imaging |
| WO1993018067A1 (en) * | 1992-03-06 | 1993-09-16 | Abbott Laboratories | Immunocapture assay for direct quantitation of specific lipoprotein cholesterol levels |
| WO1994000592A1 (en) * | 1992-06-26 | 1994-01-06 | Exocell, Inc. | Monoclonal antibodies against glycated low density lipoprotein |
| EP0671926B1 (en) * | 1992-08-11 | 2002-11-13 | President And Fellows Of Harvard College | Immunomodulatory peptides |
| KR0185334B1 (ko) | 1995-11-02 | 1999-04-01 | 김은영 | 인간 혈장 아포지단백질 비-100에 결합하는 생쥐 항체를 암호하는 씨디엔에이 |
| GB9609702D0 (en) * | 1996-05-09 | 1996-07-10 | Royal Free Hosp School Med | Anticoagulant peptides |
| GB9620153D0 (en) * | 1996-09-27 | 1996-11-13 | Univ Strathclyde | Non-naturally occurring lipoprotein particle |
| GB9705831D0 (en) * | 1997-03-20 | 1997-05-07 | Univ Leicester | Oxidised ldl |
| US6635623B1 (en) * | 1997-06-13 | 2003-10-21 | Baylor College Of Medicine | Lipoproteins as nucleic acid vectors |
| US6225070B1 (en) | 1997-08-07 | 2001-05-01 | The Regents Of The University Of California | Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma |
| US6156315A (en) * | 1997-10-10 | 2000-12-05 | The Trustees Of Columbia University In The City Of New York | Method for inhibiting the binding of low density lipoprotein to blood vessel matrix |
| EP0911344B1 (en) * | 1997-10-15 | 2004-03-03 | Fujirebio Inc. | Anti-Apo-B-48 monoclonal antibody, hybridoma, and methods of use |
| US6579682B1 (en) * | 1998-03-10 | 2003-06-17 | The Regents Of University Of California | Methods and tools for identifying compounds which modulate atherosclerosis by impacting LDL-proteoglycan binding |
| AU5200699A (en) * | 1998-07-13 | 2000-02-01 | University Of Otago | Inhibition of lipoprotein formation |
| IL126447A (en) * | 1998-10-04 | 2004-09-27 | Vascular Biogenics Ltd | An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis |
| DE60045869D1 (de) * | 1999-10-26 | 2011-06-01 | Univ California | Reagenzien und verfahren für diagnose, 'imaging' und behandlung von atherosklerotischen krankheiten |
| US20020081590A1 (en) * | 2000-02-04 | 2002-06-27 | Aeomica, Inc. | Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence |
| JP2003525883A (ja) * | 2000-03-03 | 2003-09-02 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
| SE0000855D0 (sv) * | 2000-03-15 | 2000-03-15 | Karolinska Innovations Ab | Antigenic composition useful as a vaccine against atherosclerosis |
| GB0017641D0 (en) * | 2000-07-18 | 2000-09-06 | Medigene Oy | Peptides and their use |
| EP1186299A1 (en) * | 2000-09-12 | 2002-03-13 | Universitair Medisch Centrum Utrecht | The diagnosis, prevention, and/or succesful treatment of atherosclerosis, infectious diseases, and disturbances in the immune system |
| CA2425513A1 (en) * | 2000-10-25 | 2002-06-20 | Vincent Agnello | Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| AU2002241603A1 (en) * | 2000-11-10 | 2002-06-03 | University Of Utah Research Foundation | Carrier system for specific artery wall gene delivery |
| SE0103754L (sv) * | 2001-04-05 | 2002-10-06 | Forskarpatent I Syd Ab | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid |
| RU2003136090A (ru) * | 2001-05-15 | 2005-04-20 | Джэпэн Иммьюнорисерч Лэборэтериз Ко., Лтд (Jp) | Пептид, взаимодействующий с липопротеином высокой плотности |
| MXPA04000564A (es) * | 2001-07-20 | 2005-02-17 | Univ Zuerich | Composiciones y metodos para uso de agentes bioactivos derivados de aminoacidos sulfatados y sulfonados. |
-
2001
- 2001-11-09 SE SE0103754A patent/SE0103754L/sv not_active Application Discontinuation
-
2002
- 2002-04-05 BR BR0208685-9A patent/BR0208685A/pt not_active Application Discontinuation
- 2002-04-05 DK DK02714667T patent/DK1383526T3/da active
- 2002-04-05 PL PL02367301A patent/PL367301A1/xx unknown
- 2002-04-05 EP EP10180828A patent/EP2289921A1/en not_active Withdrawn
- 2002-04-05 EP EP10181273A patent/EP2289935A1/en not_active Withdrawn
- 2002-04-05 EP EP10180826A patent/EP2289920A1/en not_active Withdrawn
- 2002-04-05 EP EP08151489A patent/EP2006301B1/en not_active Expired - Lifetime
- 2002-04-05 EP EP08167533A patent/EP2147930A3/en not_active Withdrawn
- 2002-04-05 EP EP10180026A patent/EP2295457A1/en not_active Withdrawn
- 2002-04-05 EP EP10180168A patent/EP2295461A1/en not_active Withdrawn
- 2002-04-05 EP EP10181167A patent/EP2289925A1/en not_active Withdrawn
- 2002-04-05 EP EP10181196A patent/EP2289928A1/en not_active Withdrawn
- 2002-04-05 CN CN201210322795.9A patent/CN103122031B/zh not_active Expired - Lifetime
- 2002-04-05 EP EP10181253.5A patent/EP2289934B1/en not_active Expired - Lifetime
- 2002-04-05 EP EP10180188A patent/EP2289916A1/en not_active Withdrawn
- 2002-04-05 EE EEP200300487A patent/EE200300487A/xx unknown
- 2002-04-05 DK DK08151489.5T patent/DK2006301T3/da active
- 2002-04-05 DE DE60230029T patent/DE60230029D1/de not_active Expired - Lifetime
- 2002-04-05 WO PCT/SE2002/000679 patent/WO2002080954A1/en active Application Filing
- 2002-04-05 EP EP10181203A patent/EP2289929A1/en not_active Withdrawn
- 2002-04-05 DK DK10181267.5T patent/DK2295464T3/en active
- 2002-04-05 EP EP10180156A patent/EP2295459A1/en not_active Withdrawn
- 2002-04-05 EP EP07119130A patent/EP1918300A3/en not_active Withdrawn
- 2002-04-05 EP EP10181188A patent/EP2289927A1/en not_active Withdrawn
- 2002-04-05 EP EP10180845A patent/EP2289924A1/en not_active Withdrawn
- 2002-04-05 EP EP10181227A patent/EP2289932A1/en not_active Withdrawn
- 2002-04-05 EP EP08158141A patent/EP2147928A3/en not_active Withdrawn
- 2002-04-05 EP EP10180835A patent/EP2289922A1/en not_active Withdrawn
- 2002-04-05 PL PL400308A patent/PL400308A1/pl unknown
- 2002-04-05 EP EP10180176A patent/EP2305708A1/en not_active Withdrawn
- 2002-04-05 ES ES02714667T patent/ES2317999T3/es not_active Expired - Lifetime
- 2002-04-05 EP EP10181213A patent/EP2289930A1/en not_active Withdrawn
- 2002-04-05 EP EP10180193A patent/EP2289917A1/en not_active Withdrawn
- 2002-04-05 CN CN2007101953989A patent/CN101284874B/zh not_active Expired - Lifetime
- 2002-04-05 PT PT02714667T patent/PT1383526E/pt unknown
- 2002-04-05 CN CNA2009100095655A patent/CN101486766A/zh active Pending
- 2002-04-05 EP EP10180199A patent/EP2289918A1/en not_active Withdrawn
- 2002-04-05 EE EEP200700052A patent/EE200700052A/xx unknown
- 2002-04-05 EP EP10181173A patent/EP2289926A1/en not_active Withdrawn
- 2002-04-05 ES ES10181267.5T patent/ES2546293T3/es not_active Expired - Lifetime
- 2002-04-05 EP EP08167531A patent/EP2147929A3/en not_active Ceased
- 2002-04-05 EP EP10180091A patent/EP2305706A1/en not_active Withdrawn
- 2002-04-05 EP EP10181263A patent/EP2295463A1/en not_active Withdrawn
- 2002-04-05 EP EP08167532A patent/EP2147680A3/en not_active Withdrawn
- 2002-04-05 EP EP10180184A patent/EP2295462A1/en not_active Withdrawn
- 2002-04-05 EP EP10180111A patent/EP2289914A1/en not_active Withdrawn
- 2002-04-05 EP EP02714667A patent/EP1383526B1/en not_active Expired - Lifetime
- 2002-04-05 EP EP10180109A patent/EP2289913A1/en not_active Withdrawn
- 2002-04-05 IL IL15828502A patent/IL158285A0/xx unknown
- 2002-04-05 AU AU2002246484A patent/AU2002246484B8/en not_active Expired
- 2002-04-05 AT AT02714667T patent/ATE415423T1/de active
- 2002-04-05 JP JP2002578993A patent/JP2004529143A/ja not_active Withdrawn
- 2002-04-05 EP EP10181217A patent/EP2289931A1/en not_active Withdrawn
- 2002-04-05 EP EP10181245A patent/EP2289933A1/en not_active Withdrawn
- 2002-04-05 CA CA2443223A patent/CA2443223C/en not_active Expired - Lifetime
- 2002-04-05 EP EP10181267.5A patent/EP2295464B1/en not_active Expired - Lifetime
- 2002-04-05 EP EP10180106A patent/EP2289912A1/en not_active Withdrawn
- 2002-04-05 CA CA2606839A patent/CA2606839C/en not_active Expired - Lifetime
- 2002-04-05 AT AT08151489T patent/ATE510851T1/de not_active IP Right Cessation
- 2002-04-05 RU RU2003132443/15A patent/RU2296582C2/ru active
- 2002-04-05 EP EP10180099A patent/EP2295458A1/en not_active Withdrawn
- 2002-04-05 EP EP10180838A patent/EP2289923A1/en not_active Withdrawn
- 2002-04-05 PL PL385189A patent/PL215401B1/pl unknown
- 2002-04-05 CA CA2827167A patent/CA2827167A1/en not_active Abandoned
- 2002-04-05 CN CN028089405A patent/CN1505525B/zh not_active Expired - Fee Related
- 2002-04-05 PL PL391615A patent/PL217858B1/pl unknown
- 2002-04-05 EP EP10180115A patent/EP2305707A1/en not_active Withdrawn
- 2002-04-05 EP EP10180172A patent/EP2289915A1/en not_active Withdrawn
- 2002-04-05 EP EP10180823A patent/EP2289919A1/en not_active Withdrawn
- 2002-04-05 EP EP10180162.9A patent/EP2295460B1/en not_active Expired - Lifetime
-
2003
- 2003-10-07 IL IL158285A patent/IL158285A/en active IP Right Grant
-
2007
- 2007-12-20 IL IL188286A patent/IL188286A0/en unknown
-
2008
- 2008-01-25 JP JP2008015545A patent/JP2008169215A/ja not_active Withdrawn
- 2008-11-18 IL IL195356A patent/IL195356A0/en unknown
-
2009
- 2009-02-24 CY CY20091100202T patent/CY1108817T1/el unknown
- 2009-06-02 JP JP2009133383A patent/JP5270456B2/ja not_active Expired - Fee Related
-
2010
- 2010-10-26 JP JP2010239478A patent/JP5300820B2/ja not_active Expired - Lifetime
- 2010-10-26 JP JP2010239477A patent/JP5300819B2/ja not_active Expired - Lifetime
-
2013
- 2013-02-25 JP JP2013034312A patent/JP5613890B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL195356A0 (en) | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein | |
| AT500379B1 (de) | Tau-proteine | |
| NO872473D0 (no) | Peptidblanding og fremgangsmaate ved paavisning av antistoffer htlv-iii. | |
| HK1087018A1 (en) | Peptide-based passive immunization therapy for treatment of atherosclerosis | |
| KR970027305A (ko) | 인간 혈장 아포지단백질(apolipoprotein) B-100에 결합하는 생쥐 항체를 암호하는 cDNA | |
| Tian et al. | Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease | |
| DE69635582D1 (de) | Diagnostika und behandlungen von peridontalen erkrankungen | |
| DK1167389T3 (da) | Antistoffer mod SEMP1-proteinet, fremgangsmåde til fremstilling heraf samt anvendelse deraf | |
| PT723552E (pt) | Oligopeptidos derivados de fragmentos de proteina reactiva c | |
| WO2004030607A3 (en) | Peptide-based passive immunization therapy for treatment of atherosclerosis | |
| DE69333111D1 (de) | Natürliche menschliche igm antikörper | |
| BRPI0216033B8 (pt) | "terapia de imunização à base de peptídio para tratamento de arteriosclerose" | |
| DE60336214D1 (de) | Methoden zur analyse von antikörperdisulfidisomere | |
| WO2002023202A8 (en) | Method to identify antibody targets based on mass spectrometry (maldi-tof) | |
| SE0104354D0 (sv) | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based ELISA for determination of immune responses against oxidized low-density lipoprotein |